Insulin sensitivity in patients with schizophrenia or schizoaffective disorder treated with olanzapine and risperidone

Trial Profile

Insulin sensitivity in patients with schizophrenia or schizoaffective disorder treated with olanzapine and risperidone

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2011

At a glance

  • Drugs Olanzapine; Risperidone
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Pharmacodynamics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Aug 2011 Results published in the Diabetes, Obesity and Metabolism.
    • 24 Sep 2008 Status changed from recruiting to completed.
    • 29 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top